Acquired

Relievant Medsystems Stock

Relievant provides patients with low risk therapy that affords the ability to alleviate their back pain.

Sign up today and learn more about Relievant Medsystems Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Relievant Medsystems Stock

Relievant's mission is to provide patients with low risk therapy that can alleviate their back pain.

Funding History

October 2006$5.0M
July 2009$20.0M
March 2012$30.0M
February 2015$3.0M
December 2015$1.5M
October 2016$36.0M
June 2018$58.0M

Management

President & CEO

Alex Dinello

Founder & Chief Operating Officer

Rex Peters

Press

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo